Is Cash Flow a Problem for Aurora Cannabis (TSX:ACB)?

A recent downgrade of Aurora Cannabis stock (TSX:ACB)(NYSE:ACB) has investors worried that the company might be too risky given all the cash it has been burning through.

| More on:
Canadian Dollars

Image source: Getty Images

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) was recently downgraded by an analyst amid fears that the company’s cash burn combined with convertible debt (which is not in the money) due in Q1 could become problematic.

Running low on cash in the industry has, unfortunately, been the norm rather than the exception these days. It’s an important issue and one that I highlighted in the company’s most recent quarterly results.

Let’s take a closer look at how Aurora has done this year to help assess how big of a problem a lack of cash is today.

How much cash is the company burning through?

Over the past nine months, Aurora has used up a combined $324 million to fund both its operating and investing activities. It’s no secret that the company has been recording some significant losses

Although a good chunk of that has related to non-cash items including impairment, the company has also benefitted from fair value gains as well.

One way that Aurora and other pot stocks have been able to alleviate some of their cash needs is by using stock-based compensation. During the current fiscal year, the company has paid nearly $80 million in compensation through the use of shares.

The problem is that although there are a lot of non-cash items like share-based compensation on its financials, Aurora still used up more than five times the amount of cash that it did a year ago in its day-to-day operating activities.

While that’s mainly been a result of the company’s growth, the launch of edibles and more pot shops being opened could worsen in future quarters.

Aurora has also been spending a lot on its investing activities, with $247 million being spent during the year to acquire property, plant and equipment.

Its cash burn would have been an even bigger problem if the company hadn’t gained $117 million in cash from its acquisitions. That was the main reason that the cash used from the company’s investing activities year to date was only $136 million.

The company had just $89 million on its books at the beginning of the year, and while that has increased in nine months, that’s mainly been due to loans that Aurora has taken out and, to a lesser extent, shares that it has issued.

Bottom line

Yes, Aurora has a big problem with cash burn, as do many of its peers. However, we’ve known this for some time now. The timing of the analyst’s downgrade is a bit odd and makes me wonder if it has more to do with heightened fears as a result of the CannTrust scandal.

Heading into this week, Aurora’s stock had risen more than 30% year to date, but if we factor out a very bullish January, its share price has actually fallen more than 4% since February.

The company still has a fairly strong valuation in the markets and an equity issue could certainly help alleviate concerns for the time being.

However, with more eyes now on cannabis stocks and their lack of profitability, the company is going to need to tighten up its financials.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »